On this week’s 51%, we look back at some of our biggest stories and favorite conversations of 2022. Following the Supreme Court’s decision to...
On this week’s 51%, we wrap our series on women in business. Harvard economist Claudia Goldin explains how women persisted in the job market...
The accessibility of the key abortion medication mifepristone hangs in the balance after a federal judge in Texas ruled earlier this month to suspend...